When a discolored toenail concerns you during GLP-1 treatment, a prescription solution may sound easier to fit into your routine than tablets. Tavaborole's trial results deserve careful reading: eliminating detectable fungus and obtaining a completely clear nail were separate outcomes.

Read the two cure measures separately

Complete cure occurred in 6.5% versus 0.5% with vehicle in one trial, and 9.1% versus 1.5% in the other. Negative fungal testing was more common: 31.1% versus 7.2%, and 35.9% versus 12.2%. Both outcomes significantly favored tavaborole over the solution without active drug. [1]

Negative fungal tests do not establish a normal-looking nail. Ask which outcome supports a quoted percentage.

Adults had 20% to 60% involvement of the target great toenail. Follow-up duration was a stated limitation. The vehicle comparisons cannot rank tavaborole against tablets or another solution. [1]

Confirm what caused the nail change

AAD explains that nail psoriasis and injury can resemble fungal infection. A dermatologist may examine a clipping, scraping or buildup sample under a microscope to confirm fungus and help select treatment. The choice also depends on health, other medicines, the affected nail area and the fungus involved. [3]

Bring photographs showing when the change began, plus the names of anything already applied. Include your GLP-1 prescription in the medication list. The tavaborole studies were toenail-fungus trials; they do not show that the medicine treats nail changes caused by GLP-1 therapy.

Plan for the application and the bottle's lifespan

The US label directs once-daily use for 48 weeks over the entire affected toenail surface and under its tip. The nail should be clean and dry; let the solution dry after applying and wash your hands. Have the prescriber or pharmacist demonstrate the directions for your bottle. [2]

The solution is flammable, so keep it away from heat and flame. The label says to discard the bottle three months after inserting its dropper. Record that date and ask the pharmacy how refills will cover the prescribed course. [2]

Discuss nail polish before covering the nail

The label says it is unknown whether polish, gels or acrylic nail products affect how tavaborole works. Ask the prescriber about your planned pedicure. Report persistent application-site irritation, such as redness, itching or swelling. Peeling and ingrown toenails are among the common reported reactions. [2]

AAD advises continuing prescribed nail treatment for the instructed duration even when symptoms begin improving. Nails grow slowly, and fungal infection can return after clearing. Tell the clinician about pregnancy, plans for pregnancy or breastfeeding when discussing treatment options. [3]

For an oral option, read the terbinafine trial and safety review. For another topical approach, see the efinaconazole cure-rate guide.

This article provides general education, not a diagnosis or an individual treatment plan. Medication information refers to US sources. Discuss medication, nutrition and cosmetic treatment decisions with qualified clinicians.

Sources

  1. Tavaborole 5% for toenail fungus: two randomized phase 3 studiesElewski and colleagues, Journal of the American Academy of Dermatology, 2015; primary abstract↩ Back to text
  2. Tavaborole topical solution 5%: US prescribing and patient informationViona Pharmaceuticals; DailyMed, updated December 6, 2024↩ Back to text
  3. Nail fungus: Diagnosis and treatmentAmerican Academy of Dermatology↩ Back to text